Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

INVO Fertility (IVF) Long-Term Debt Issuances (2011 - 2024)

INVO Fertility (IVF) reported Long-Term Debt Issuances of $650000.0 for Q4 2024, up 121.96% year-over-year from $292848.7 in Q1 2024, and up 158.19% on a QoQ basis from $251750.0 in Q3 2024.

INVO Fertility (IVF) has 6 years of Long-Term Debt Issuances data on file, last reported at $650000.0 in Q4 2024.

  • Quarterly Long-Term Debt Issuances rose 121.96% year-over-year to $650000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.3 million (up 1244.25% YoY) and the FY2024 annual result came in at $1.3 million, up 1244.25% from the prior year.
  • Long-Term Debt Issuances rose to $650000.0 in Q4 2024 per IVF's latest filing, from $251750.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $2.3 million in Q3 2023 and bottomed at -$3.0 million in Q4 2023.
  • The 4-year median for Long-Term Debt Issuances is $221250.0 (2024), against an average of -$164933.0.
  • The widest annual swing landed in 2023, when Long-Term Debt Issuances tumbled 3060.25%; it then surged 121.96% in 2024.
  • Tracing IVF's Long-Term Debt Issuances over 4 years: stood at -$2.5 million in 2020, then surged by 104.02% to $100000.0 in 2022, then plunged by 3060.25% to -$3.0 million in 2023, then jumped by 121.96% to $650000.0 in 2024.
  • Per Business Quant, the three latest IVF Long-Term Debt Issuances figures stand at $650000.0 (Q4 2024), $251750.0 (Q3 2024), and $217500.0 (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 19.86 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.15 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 INVO Fertility 5.12 Mn 4.76 Mn 629,345.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 650,000.00
Dec 31, 2024 650,000.00
Sep 30, 2024 251,750.00
Sep 30, 2024 251,750.00
Jun 30, 2024 217,500.00
Jun 30, 2024 217,500.00
Mar 31, 2024 225,000.00
Mar 31, 2024 225,000.00
Dec 31, 2023 -2.96 Mn
Dec 31, 2023 -2.96 Mn
Sep 30, 2023 2.35 Mn
Sep 30, 2023 2.35 Mn
Mar 31, 2023 714,000.00
Mar 31, 2023 714,000.00
Dec 31, 2022 100,000.00
Dec 31, 2022 100,000.00
Sep 30, 2020 -2.49 Mn
Sep 30, 2020 -2.49 Mn
Jun 30, 2020 -706,690.00
Jun 30, 2020 -706,690.00
Dec 31, 2018 815,000.00
Dec 31, 2018 815,000.00
Dec 31, 2011 87,500.00
Dec 31, 2011 87,500.00
Sep 30, 2011 -13,000.00
Sep 30, 2011 -13,000.00